In accordance with the ‘Drug Approval Change Order’ (Drug Safety Evaluation Division-No. 2298, effective date April 21, 2017), the precautions for use of Inhipla Tablet have been changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.